ES2174450T3 - Derivados de benzo(5,6)ciclohepta(1,2-b)piridina como inhibidores de la farnesil-protein-transferasa. - Google Patents

Derivados de benzo(5,6)ciclohepta(1,2-b)piridina como inhibidores de la farnesil-protein-transferasa.

Info

Publication number
ES2174450T3
ES2174450T3 ES98930063T ES98930063T ES2174450T3 ES 2174450 T3 ES2174450 T3 ES 2174450T3 ES 98930063 T ES98930063 T ES 98930063T ES 98930063 T ES98930063 T ES 98930063T ES 2174450 T3 ES2174450 T3 ES 2174450T3
Authority
ES
Spain
Prior art keywords
alkyl
ciclohepta
transferasa
farnesil
piridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98930063T
Other languages
English (en)
Inventor
Timothy J Guzi
Dinanath F Rane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2174450T3 publication Critical patent/ES2174450T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Un compuesto de fórmula: o una de sus sales o solvatos farmacéuticamente aceptable, en la que: a representa N o NO-; R1 y R3 son el mismo o diferente átomo de halógeno; R2 y R4 se seleccionan de H y halógeno, con la condición de que al menos uno de R2 y R4 sea H; las líneas de trazos (---) representan un enlace opcional; X es N, C cuado el enlace opcional está presente, o CH cuando no hay enlace opcional; T representa en la que R5 representa H, alquilo (C1-C6) o un enlace; b y c son independientemente de 0 a 3; e Y representa R6 representa alquilo (C1-C6) o H; Z representa OR7, R7 o NR8R9; R7 representa H, alquilo (C1-C6) o alquilo (C1-C6) sustituido con OR5, COR5, fenilo o piridilo; R8 y R9, representan independientemente H, OH, alquilo (C1-C6) o alquilo (C1-C6) sustituido con OR5, COR5, fenilo, o piridilo, o R8 y R9 considerados juntos con el átomo de nitrógeno en NR8R9 forman un sistema de anillo de heterociclo de cinco o seis miembros, sustituido o no sustituido, que contiene carbono y heteroátomos seleccionados de N, O, S, SO o SO2, siendo dichos sustituyentes de heterociclo, alcanoilo (C1-C8), alquilo (C1-C6) o perhalógenoalquilo (C1-C6).
ES98930063T 1997-06-17 1998-06-15 Derivados de benzo(5,6)ciclohepta(1,2-b)piridina como inhibidores de la farnesil-protein-transferasa. Expired - Lifetime ES2174450T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87650797A 1997-06-17 1997-06-17

Publications (1)

Publication Number Publication Date
ES2174450T3 true ES2174450T3 (es) 2002-11-01

Family

ID=25367883

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98930063T Expired - Lifetime ES2174450T3 (es) 1997-06-17 1998-06-15 Derivados de benzo(5,6)ciclohepta(1,2-b)piridina como inhibidores de la farnesil-protein-transferasa.

Country Status (12)

Country Link
EP (1) EP0991637B1 (es)
JP (1) JP2002510308A (es)
KR (1) KR20010013829A (es)
CN (1) CN1272844A (es)
AT (1) ATE218137T1 (es)
AU (1) AU7953798A (es)
CA (1) CA2293433C (es)
DE (1) DE69805619T2 (es)
ES (1) ES2174450T3 (es)
HU (1) HUP0002659A3 (es)
IL (1) IL133448A0 (es)
WO (1) WO1998057945A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020077301A1 (en) * 2000-10-05 2002-06-20 Whitehead Institute For Biomedical Research Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors
CA2424797C (en) 2000-10-05 2009-12-29 George Q. Daley Methods of inducing cancer cell death and tumor regression
US7098241B2 (en) 2002-12-16 2006-08-29 Hoffmann-La Roche Inc. Thiophene hydroxamic acid derivatives
JP2024525589A (ja) 2021-07-09 2024-07-12 アリゴス セラピューティクス インコーポレイテッド 抗ウイルス化合物
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
KR920014799A (ko) * 1991-01-18 1992-08-25 나오가따 다이도 신규벤조[5,6]시클로헵타[1,2-b]피리딘 유도체 및 이를 함유하는 항알레르기제
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
EP0991637B1 (en) 2002-05-29
DE69805619D1 (en) 2002-07-04
ATE218137T1 (de) 2002-06-15
CN1272844A (zh) 2000-11-08
HUP0002659A3 (en) 2002-11-28
HUP0002659A2 (hu) 2001-06-28
HK1024910A1 (en) 2000-10-27
WO1998057945A1 (en) 1998-12-23
CA2293433C (en) 2009-09-29
AU7953798A (en) 1999-01-04
CA2293433A1 (en) 1998-12-23
IL133448A0 (en) 2001-04-30
KR20010013829A (ko) 2001-02-26
DE69805619T2 (de) 2002-11-07
EP0991637A1 (en) 2000-04-12
JP2002510308A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
BRPI0506817A (pt) inibidores seletivos de quinase
HRP20080186T3 (en) Use of tricyclic compounds as glycine transport inhibitors
DK419086A (da) Heterocykliske substituerede indoler, mellemprodukter, fremgangsmaader til fremstilling heraf og laegemidler
AR038536A1 (es) N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
CO5540299A2 (es) Derivados de tiazol u oxazol que son utiles en el tratamiento de enfermedades cardiovasculares y relacionadas
EA200601235A1 (ru) Производные тиазола
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
ATE136293T1 (de) Aromatische amidinderivate und ihre salze
CO5031251A1 (es) 1-aril, 4-ciclopropil pirazoles parasiticidas y procedimientos para su obtencion
CO4940458A1 (es) Novedosos inhibidores de urea n-sustituida de transferasa de proteina farnesilo
AR011913A1 (es) Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
ES2191484T3 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
DE69835460D1 (de) Indolecarbonsäurederivate und ihre Verwendung als Arzneimittel
CO5640109A2 (es) Compuestos triciclicos inhibidores de la farnesisl proteino transferasa y composiciones farmaceuticas que los contienen
DK0542609T3 (da) 3-sulfonylamino-2-(1H)-quinolinon og 7-azaderivater heraf som excitatoriske aminosyre-anta-gonister
ES2174450T3 (es) Derivados de benzo(5,6)ciclohepta(1,2-b)piridina como inhibidores de la farnesil-protein-transferasa.
ES2177275T3 (es) Derivados de oxadiazolina y su uso como insecticidas.
DK304289A (da) Benzenderivater
IS1746B (is) Hliðstæð aðferð til tilreiðslu á nýjum afleiðum thiazolidinone og oxazolidinone sem gagnlegar eru til æðaútvíkkunar
ES2193923T3 (es) Ciano-indoles como inhibidores de recaptura de serotonina y ligandos del receptor 5-ht2c.
ATE504572T1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
AR002259A1 (es) Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion, compuestos intermedios y composicion que contiene a dichos derivados.
ATE118207T1 (de) Heterozyklische acylaminodiol-beta-aminosäure- derivate.
ES2174582T3 (es) Nuevos derivados de 1,2-ditiolano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE69802T1 (de) Ungesaettigte derivate von methylendianilin.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 991637

Country of ref document: ES